Emdeon (EM) Tops Q3 EPS by 2c; Guides In-line for FY09
More News related to EM
- Emdeon to Present at the Piper Jaffray Annual Health Care Conference
- Emdeon CEO Pens Chapter in 'Stop Paying the Crooks: Solutions to End the Fraud That Threatens Your Healthcare'
- Morgan Stanley Upgrades Emdeon (EM) to Overweight
- U.S. Healthcare Efficiency Index(TM) Launches Primary Data Collection to Measure Current State of Electronic Adoption and Potential Cost Savings
- After-Hours Movers 11/10: BITS, GSB, OCNF, HOO Higher; TGIC, MCZ, STV, MBLX, EM Lower
Emdeon Inc. (NYSE: EM) reports Q3 adjusted EPS of $0.21, 2 cents better than the analyst estimate of $0.19. Revenue for the quarter was $235.5 million, which compares to the estimate of $233.87 million.
Emdeon currently anticipates its annual revenue, Adjusted EBITDA and Adjusted Net Income per fully diluted share for 2009 to be as follows:
2009 revenue to be between $915 to $925 million vs. consensus of $918.54 million.
2009 Adjusted Net Income per fully diluted share to be between $0.80 to $0.86 vs. consensus of $0.80.
2009 Adjusted EBITDA to be between $234 to $239 million
Related Categories
EarningsGuidance
Stocks Mentioned
-0.31Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
